Financhill
Sell
17

NUTX Quote, Financials, Valuation and Earnings

Last price:
$29.23
Seasonality move :
9.24%
Day range:
$28.85 - $30.46
52-week range:
$4.16 - $41.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.37x
P/B ratio:
2.64x
Volume:
25.3K
Avg. volume:
59.4K
1-year change:
8.81%
Market cap:
$159.7M
Revenue:
$247.6M
EPS (TTM):
-$10.79
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $97.1M $274M $331.5M $219.3M $247.6M
Revenue Growth (YoY) -- 182.34% 20.98% -33.85% 12.93%
 
Cost of Revenues -- $116.4M $152.3M $203.9M $212.9M
Gross Profit -- $157.6M $179.3M $15.4M $34.8M
Gross Profit Margin -- 57.51% 54.08% 7.03% 14.04%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $59.9M $4.4M $5.5M $20M $36.1M
Other Inc / (Exp) $909.2K -$1M $1.9M -$402.6M -$30.7M
Operating Expenses $62.3M $4.4M $5.5M $20M $36.3M
Operating Income $34.7M $153.2M $173.8M -$4.6M -$1.5M
 
Net Interest Expenses $3.5M $6.4M $6.2M $12.5M $16.3M
EBT. Incl. Unusual Items $32.1M $145.7M $169.5M -$419.6M -$48.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $181.3K $965.7K $13.1M -$5.1M
Net Income to Company $32.1M $145.6M $168.5M -$432.7M -$43.4M
 
Minority Interest in Earnings -$11.2M -$39.6M -$35.9M $8M -$2.4M
Net Income to Common Excl Extra Items $20.9M $106M $132.6M -$424.8M -$45.8M
 
Basic EPS (Cont. Ops) $4.88 $24.69 $30.90 -$100.50 -$10.50
Diluted EPS (Cont. Ops) $4.88 $24.69 $30.90 -$100.50 -$10.50
Weighted Average Basic Share $4.3M $4.3M $4.3M $4.2M $4.4M
Weighted Average Diluted Share $4.3M $4.3M $4.3M $4.2M $4.4M
 
EBITDA $38.1M $158.1M $183.3M -$394M -$14.6M
EBIT $35.6M $152.2M $175.7M -$407.2M -$32.2M
 
Revenue (Reported) $97.1M $274M $331.5M $219.3M $247.6M
Operating Income (Reported) $34.7M $153.2M $173.8M -$4.6M -$1.5M
Operating Income (Adjusted) $35.6M $152.2M $175.7M -$407.2M -$32.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $118M $28.4M $62.7M $78.8M
Revenue Growth (YoY) -- -- -75.93% 120.89% 25.62%
 
Cost of Revenues -- $42M $52.1M $55.7M $56.9M
Gross Profit -- $76M -$23.7M $7.1M $21.9M
Gross Profit Margin -- 64.43% -83.51% 11.27% 27.82%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $1.5M $6.8M $7.8M $11.8M
Other Inc / (Exp) -- $1.7M -$397.5M $9.7K -$7.3M
Operating Expenses -- $1.5M $6.8M $7.8M $11.8M
Operating Income -- $74.5M -$30.5M -$777.8K $10.1M
 
Net Interest Expenses -- $1.3M $3.4M $4.1M $5.4M
EBT. Incl. Unusual Items -- $74.9M -$431.5M -$4.9M -$2.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $453.6K -$8.5M -$342.3K $4.6M
Net Income to Company -- $74.5M -$422.9M -$4.5M -$7.2M
 
Minority Interest in Earnings -- -$20.7M $10.7M -$1M -$1.6M
Net Income to Common Excl Extra Items -- $53.8M -$412.2M -$5.5M -$8.8M
 
Basic EPS (Cont. Ops) -- $12.53 -$93.00 -$1.25 -$1.72
Diluted EPS (Cont. Ops) -- $12.53 -$93.00 -$1.25 -$1.72
Weighted Average Basic Share -- $4.3M $4.3M $4.4M $5.1M
Weighted Average Diluted Share -- $4.3M $4.3M $4.4M $5.1M
 
EBITDA -- $78.1M -$423.7M $4M $7.8M
EBIT -- $76.2M -$428.1M -$768K $2.8M
 
Revenue (Reported) -- $118M $28.4M $62.7M $78.8M
Operating Income (Reported) -- $74.5M -$30.5M -$777.8K $10.1M
Operating Income (Adjusted) -- $76.2M -$428.1M -$768K $2.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $289.5M $229M $231.7M $292M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- $190.7M $213.5M $224.2M
Gross Profit -- -- $38.2M $18.2M $67.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -$62.1M $17.9M $29.4M $40.3M
Other Inc / (Exp) -- $4.1M -$406.2M -$326.6K -$38M
Operating Expenses -- -$66.2M $17.9M $29.6M $40.3M
Operating Income -- $162.1M $20.3M -$11.4M $27.6M
 
Net Interest Expenses -- $4.8M $11.6M $14.9M $19.1M
EBT. Incl. Unusual Items -- $161.4M -$397.4M -$26.6M -$29.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $11.2M -$263.4K $2.9M
Net Income to Company -- -- -$408.6M -$26.4M -$32.4M
 
Minority Interest in Earnings -- -$38.4M $12.6M -$2.6M -$8.7M
Net Income to Common Excl Extra Items -- $121.8M -$396M -$28.9M -$41.1M
 
Basic EPS (Cont. Ops) -- $28.38 -$89.25 -$23.04 -$10.79
Diluted EPS (Cont. Ops) -- $28.38 -$89.25 -$23.04 -$10.79
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $172.7M -$374.2M $4.5M $8M
EBIT -- $166.2M -$385.9M -$11.7M -$10.4M
 
Revenue (Reported) -- $289.5M $229M $231.7M $292M
Operating Income (Reported) -- $162.1M $20.3M -$11.4M $27.6M
Operating Income (Adjusted) -- $166.2M -$385.9M -$11.7M -$10.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $182.8M $165.6M $178M $222.3M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $77.2M $146.8M $156.4M $167.7M
Gross Profit -- $105.6M $18.7M $21.6M $54.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $76.7K -- -- --
Selling, General & Admin -- $7.5M $17.5M $26.9M $31.1M
Other Inc / (Exp) -- $5.8M -$402.4M -$114.2K -$7.5M
Operating Expenses -- $7.7M $17.5M $27.1M $31.1M
Operating Income -- $97.9M $1.2M -$5.6M $23.5M
 
Net Interest Expenses -- $3.1M $9.6M $12.1M $14.9M
EBT. Incl. Unusual Items -- $100.6M -$410.8M -$17.8M $1.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $935.1K $11.3M -$2.1M $5.9M
Net Income to Company -- $155.1M -$422.1M -$15.7M -$4.7M
 
Minority Interest in Earnings -- -$23.3M $12.1M $1.5M -$4.8M
Net Income to Common Excl Extra Items -- $76.4M -$410M -$14.2M -$9.5M
 
Basic EPS (Cont. Ops) -- $17.80 -$92.50 -$20.04 -$3.29
Diluted EPS (Cont. Ops) -- $17.80 -$92.50 -$20.04 -$3.29
Weighted Average Basic Share -- $12.9M $12.9M $9.1M $10.3M
Weighted Average Diluted Share -- $12.9M $12.9M $9.1M $10.3M
 
EBITDA -- $109.6M -$391.3M $7.2M $29.7M
EBIT -- $103.7M -$401.2M -$5.7M $16.1M
 
Revenue (Reported) -- $182.8M $165.6M $178M $222.3M
Operating Income (Reported) -- $97.9M $1.2M -$5.6M $23.5M
Operating Income (Adjusted) -- $103.7M -$401.2M -$5.7M $16.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $8M $25.5M $36.1M $34.3M $22M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $36.1M $108.1M $114.8M $58.3M $62.8M
Inventory $899.9K $1.7M $2.8M $3.5M $3.4M
Prepaid Expenses $700.1K $130.6K -- -- --
Other Current Assets -- -- $323.3K $1.9M $2.7M
Total Current Assets $45.7M $135.5M $154M $98M $90.8M
 
Property Plant And Equipment $131.3M $170.8M $238.4M $295.2M $269.4M
Long-Term Investments -- -- -- -- --
Goodwill $1.1M $1.1M $1.1M $17M $17.1M
Other Intangibles -- -- $682.7K $21.2M $20.5M
Other Long-Term Assets $1.1M $1.1M $456.1K $423.4K $431.1K
Total Assets $179.2M $308.6M $394.7M $431.8M $398.2M
 
Accounts Payable $5.3M $8.6M $17.7M $27.5M $25.3M
Accrued Expenses $3.2M $2.4M $6.9M $6.2M $13M
Current Portion Of Long-Term Debt $10.8M $17.7M $10.2M $12.5M $10.8M
Current Portion Of Capital Lease Obligations $50.3M $1.7M $2.9M $5.9M $5.9M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $72.1M $31.5M $37.7M $54.9M $58.3M
 
Long-Term Debt $40.9M $81.9M $78.8M $23.1M $26.3M
Capital Leases -- -- -- -- --
Total Liabilities $128.4M $161.2M $203.1M $311.4M $319.1M
 
Common Stock -- -- $592.8K $650.2K $676.7K
Other Common Equity Adj -- -- -- -- --
Common Equity $28.3M $85.8M $114.7M $95.9M $61.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $22.5M $61.6M $76.9M $24.5M $17.7M
Total Equity $50.8M $147.4M $191.6M $120.3M $79.1M
 
Total Liabilities and Equity $179.2M $308.6M $394.7M $431.8M $398.2M
Cash and Short Terms $8M $25.5M $36.1M $34.3M $22M
Total Debt $54.2M $100.5M $89.1M $38.2M $40.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $34.2M $36.6M $26.8M $46.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $143.7M $63.3M $54.7M $66.3M
Inventory -- $1.7M $3.2M $2.7M $2.3M
Prepaid Expenses -- $545.6K $4.4M -- --
Other Current Assets -- -- -- $5.6M $4.3M
Total Current Assets -- $180.3M $107.5M $89.9M $119.8M
 
Property Plant And Equipment -- $189.6M $287.9M $349.8M $288.2M
Long-Term Investments -- -- -- -- --
Goodwill -- $1.1M $17M $17.9M $13.9M
Other Intangibles -- -- $21.6M $21.6M $15.9M
Other Long-Term Assets -- $1.1M $445.8K $419.9K $767.9K
Total Assets -- $372.1M $434.5M $479.6M $438.5M
 
Accounts Payable -- $15M $21.4M $23.7M $16.7M
Accrued Expenses -- $4.1M $10.3M $14.8M $22.1M
Current Portion Of Long-Term Debt -- $19.7M $4M $19.6M $10.5M
Current Portion Of Capital Lease Obligations -- $1.8M $5.6M $5.7M $7.3M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- $40.7M $43.8M $67.3M $67.6M
 
Long-Term Debt -- $71.9M $24.7M $19.3M $26.8M
Capital Leases -- -- -- -- --
Total Liabilities -- $159M $302M $374.7M $358.7M
 
Common Stock -- -- $649.8K $670.7K $5.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $91.7M $22M $15M $19.3M
Total Equity -- $213.1M $132.5M $104.9M $79.8M
 
Total Liabilities and Equity -- $372.1M $434.5M $479.6M $438.5M
Cash and Short Terms -- $34.2M $36.6M $26.8M $46.9M
Total Debt -- $91.6M $31.3M $42.3M $40.7M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $32.1M $145.6M $168.5M -$432.7M -$43.4M
Depreciation & Amoritzation $2.5M $5.9M $7.7M $13.1M $17.6M
Stock-Based Compensation -- -- -- $189.6K $2.8M
Change in Accounts Receivable -$24.7M -$71.2M -$6.6M $58.1M -$4.6M
Change in Inventories -$486.3K -$825.8K -$1.1M -$719.1K $142.7K
Cash From Operations $12.1M $86.7M $173.4M $50.6M $1.3M
 
Capital Expenditures $32.3M $61.2M $36.9M $14.6M $9.5M
Cash Acquisitions $1M -- -$48.9K $10.3M -$1.7M
Cash From Investing -$31.2M -$61.2M -$37M -$4.3M -$11.2M
 
Dividends Paid (Ex Special Dividend) -$18.9M -$59.1M -$144.3M -$51.2M -$5.2M
Special Dividend Paid
Long-Term Debt Issued $41.5M $58.2M $19.6M $3.4M $24.2M
Long-Term Debt Repaid -$5.9M -$16.9M -$22.8M -$9M -$21.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $5M $9.8M $21.7M $4.5M $298K
Cash From Financing $21.7M -$8M -$125.9M -$48.1M -$2.3M
 
Beginning Cash (CF) $5.4M $8M $25.5M $36.1M $34.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.6M $17.5M $10.6M -$1.9M -$12.3M
Ending Cash (CF) $8M $25.5M $36.1M $34.3M $22M
 
Levered Free Cash Flow -$20.2M $25.5M $136.5M $36M -$8.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $74.5M -$422.9M -$4.5M -$7.2M
Depreciation & Amoritzation -- $1.9M $4.3M $4.7M $5M
Stock-Based Compensation -- -- $81.3K $49.2K $2M
Change in Accounts Receivable -- -$52.9M $34.4M -$2.6M -$1.1M
Change in Inventories -- -$2.4K -$306.2K -$231.9K $500.3K
Cash From Operations -- $24.3M -$7.3M $2M $6.8M
 
Capital Expenditures -- $3.5M $5.9M $2.9M $617.2K
Cash Acquisitions -- -- -- -$743.8K $350K
Cash From Investing -- -$3.5M -$5.9M -$3.6M -$267.2K
 
Dividends Paid (Ex Special Dividend) -- -$23.2M -$2.1M -$1.6M -$1.8M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $1.3M $5.3M $1.3M $3.1M
Long-Term Debt Repaid -- -$4.1M -$1M -$3.9M -$3.2M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $1.5M $94.3K -- $660.1K
Cash From Financing -- -$24.6M $2.2M -$4.3M -$421K
 
Beginning Cash (CF) -- $38M $47.6M $32.8M $40.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -$3.8M -$11M -$5.9M $6.1M
Ending Cash (CF) -- $34.2M $36.6M $26.8M $46.9M
 
Levered Free Cash Flow -- $20.8M -$13.2M -$907.2K $6.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$408.6M -$26.4M -$32.4M
Depreciation & Amoritzation -- -- $11.6M $16.2M $18.4M
Stock-Based Compensation -- -- $135.4K $2.3M $2.6M
Change in Accounts Receivable -- -- $83.7M $6.8M -$11.8M
Change in Inventories -- -- -$1.5M $530.7K $423.5K
Cash From Operations -- -- $92.5M $7.5M $21.3M
 
Capital Expenditures -- $25.2M $34.2M $2.4M $1.1M
Cash Acquisitions -- -- $10.2M -$1.8M -$321.4K
Cash From Investing -- -- -$24M -$4.2M -$1.4M
 
Dividends Paid (Ex Special Dividend) -- -$101.7M -$92.6M -$5.6M -$4.5M
Special Dividend Paid
Long-Term Debt Issued -- -- $17M $10.9M $12.2M
Long-Term Debt Repaid -- -- -$9.3M -$18.2M -$18.1M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $14M $338K --
Cash From Financing -- -- -$66.2M -$13.1M $162.8K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $2.4M -$9.8M $20.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- $58.3M $5.1M $20.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $155.1M -$422.1M -$15.7M -$4.7M
Depreciation & Amoritzation -- $5.9M $9.9M $12.9M $13.7M
Stock-Based Compensation -- -- $135.4K $2.2M $2M
Change in Accounts Receivable -- -$35.6M $54.8M $3.5M -$3.7M
Change in Inventories -- -$4.9K -$399.2K $850.6K $1.1M
Cash From Operations -- $127M $46.1M $3M $23.1M
 
Capital Expenditures -- $25.2M $22.5M $10.3M $1.9M
Cash Acquisitions -- -- $10.3M -$1.8M -$361.3K
Cash From Investing -- -$25.2M -$12.2M -$12.1M -$2.3M
 
Dividends Paid (Ex Special Dividend) -- -$101.7M -$50M -$4.3M -$3.7M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $15.3M $12.7M $20.2M $8.1M
Long-Term Debt Repaid -- -$19.2M -$5.7M -$14.9M -$11.4M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $12.5M $4.8M $649.6K $960.9K
Cash From Financing -- -$93.1M -$33.4M $1.6M $4.1M
 
Beginning Cash (CF) -- $41.8M $119.3M $99.8M $92.8M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $8.7M $502.5K -$7.4M $24.9M
Ending Cash (CF) -- $76M $119.8M $92.4M $117.7M
 
Levered Free Cash Flow -- $101.8M $23.6M -$7.3M $21.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 14.24% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 22.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock